Hansa Biopharma licenses IDEFIRIX to SERB Pharmaceuticals in €115 million deal
SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization
SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization
30,000 sq. ft. multispeciality facility aims to deliver integrated care for women across every life stage
CoMira Diagnostics will manufacture PCR diagnostic instruments and medical consumables in Sudair Industrial City
The timing of the partnership is crucial, as Kerala’s fertility rate has dropped to approximately 1.35–1.7 children per woman, below the replacement level of 2.1
To support this launch, ImmunityBio has established a wholly owned subsidiary in Saudi Arabia
40+ most innovative startups with disruptive contributions across MedTech, Medical Devices, BioPharma, Cell and Gene Therapy, AI and ML, Nutraceuticals, and Biomarkers exhibited their cutting-edge solutions
The upcoming Phase I trial will test the safety, tolerability, and pharmacokinetics of ISM8969 in healthy volunteers and determine the optimal dosing for future studies
Within India, Dabur expects its Home & Personal Care business to deliver double-digit growth,
Subscribe To Our Newsletter & Stay Updated